Atlas Trials

An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males

Clinical trial NCT01932528 · COMPLETED

Trial details

NCT number
NCT01932528
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoid Syndrome
Start date
2013-08-01
Primary completion
2013-09-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.